DSG2
Desmoglein-2
Also known as: CDHF5, DSG2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14126
- Gene
- DSG2
- Ensembl
- ENSG00000046604
- Chromosome
- 18
- Canonical length
- 1118 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cell Junctions
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
1118 residues, UniProt reviewed canonical sequence.
>Q14126|DSG2
1 MARSPGRAYA LLLLLICFNV GSGLHLQVLS TRNENKLLPK HPHLVRQKRA WITAPVALRE
61 GEDLSKKNPI AKIHSDLAEE RGLKITYKYT GKGITEPPFG IFVFNKDTGE LNVTSILDRE
121 ETPFFLLTGY ALDARGNNVE KPLELRIKVL DINDNEPVFT QDVFVGSVEE LSAAHTLVMK
181 INATDADEPN TLNSKISYRI VSLEPAYPPV FYLNKDTGEI YTTSVTLDRE EHSSYTLTVE
241 ARDGNGEVTD KPVKQAQVQI RILDVNDNIP VVENKVLEGM VEENQVNVEV TRIKVFDADE
301 IGSDNWLANF TFASGNEGGY FHIETDAQTN EGIVTLIKEV DYEEMKNLDF SVIVANKAAF
361 HKSIRSKYKP TPIPIKVKVK NVKEGIHFKS SVISIYVSES MDRSSKGQII GNFQAFDEDT
421 GLPAHARYVK LEDRDNWISV DSVTSEIKLA KLPDFESRYV QNGTYTVKIV AISEDYPRKT
481 ITGTVLINVE DINDNCPTLI EPVQTICHDA EYVNVTAEDL DGHPNSGPFS FSVIDKPPGM
541 AEKWKIARQE STSVLLQQSE KKLGRSEIQF LISDNQGFSC PEKQVLTLTV CECLHGSGCR
601 EAQHDSYVGL GPAAIALMIL AFLLLLLVPL LLLMCHCGKG AKGFTPIPGT IEMLHPWNNE
661 GAPPEDKVVP SFLPVDQGGS LVGRNGVGGM AKEATMKGSS SASIVKGQHE MSEMDGRWEE
721 HRSLLSGRAT QFTGATGAIM TTETTKTARA TGASRDMAGA QAAAVALNEE FLRNYFTDKA
781 ASYTEEDENH TAKDCLLVYS QEETESLNAS IGCCSFIEGE LDDRFLDDLG LKFKTLAEVC
841 LGQKIDINKE IEQRQKPATE TSMNTASHSL CEQTMVNSEN TYSSGSSFPV PKSLQEANAE
901 KVTQEIVTER SVSSRQAQKV ATPLPDPMAS RNVIATETSY VTGSTMPPTT VILGPSQPQS
961 LIVTERVYAP ASTLVDQPYA NEGTVVVTER VIQPHGGGSN PLEGTQHLQD VPYVMVRERE
1021 SFLAPSSGVQ PTLAMPNIAV GQNVTVTERV LAPASTLQSS YQIPTENSMT ARNTTVSGAG
1081 VPGPLPDFGL EESGHSNSTI TTSSTRVTKH STVQHSYSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DSG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 149 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 149 nTPM
- colon: 99 nTPM
- rectum: 94 nTPM
- small intestine: 80 nTPM
- duodenum: 75 nTPM
- stomach: 73 nTPM
Single-cell type
- foveolar cells: 389 nCPM
- colonocytes: 381 nCPM
- urothelial cells: 346 nCPM
- gastric progenitor cells: 241 nCPM
- parietal cells: 235 nCPM
- enteric transient amplifying cells: 211 nCPM
Immune cell
- basophil: 8.7 nTPM
- plasmacytoid DC: 0.7 nTPM
- naive CD4 T-cell: 0.2 nTPM
- neutrophil: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- memory B-cell: 0.1 nTPM
Brain region
- choroid plexus: 63 nTPM
- cerebellum: 6.1 nTPM
- hippocampal formation: 5.1 nTPM
- cerebral cortex: 4.9 nTPM
- white matter: 4.9 nTPM
- midbrain: 4.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DSG2.
Disease | AllUniProt
Conditions DSG2 is implicated in, by any mechanism.
- Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) MIM:610193
- Cardiomyopathy, dilated, 1BB (CMD1BB) MIM:612877
Disease | GeneticClinVar
133 pathogenic / likely-pathogenic of 2,294 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Arrhythmogenic right ventricular dysplasia 10
- Cardiovascular phenotype
- Dilated cardiomyopathy 1BB
- Arrhythmogenic right ventricular cardiomyopathy
- Cardiomyopathy
ReferencesPubMed · IEDB
Publications for DSG2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
13 publications
- An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.
2018 · Eur Heart J · RCR 5 · 125 citations - Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.
2013 · PLoS One · RCR 1.9 · 55 citations - Stabilization of desmoglein-2 binding rescues arrhythmia in arrhythmogenic cardiomyopathy.
2020 · JCI Insight · RCR 1.3 · 25 citations - High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples.
2022 · J Mol Cell Cardiol · RCR 1.3 · 17 citations - Prevalence and Correlates of Anti-DSG2 Antibodies in Arrhythmogenic Right Ventricular Cardiomyopathy and Myocarditis: Immunological Insights from a Multicenter Study.
2024 · J Clin Med · RCR 1.2 · 6 citations
Show 8 more
- SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection.
2023 · Clin Exp Immunol · RCR 0.9 · 9 citations - Evaluation of autoantibodies to desmoglein-2 in dogs with and without cardiac disease.
2023 · Sci Rep · RCR 0.9 · 6 citations - Autoantibodies against desmoglein 2 are not pathogenic in pemphigus.
2022 · An Bras Dermatol · RCR 0.5 · 6 citations - No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases.
2003 · J Dermatol Sci · RCR 0.3 · 15 citations - Loss of correlation between intensities of desmoglein 2 and desmoglein 3 expression in basal cell carcinomas.
2011 · Acta Dermatovenerol Croat · RCR 0.2 · 8 citations - Anti-desmoglein-2 autoantibodies do not discriminate between UK boxer dogs with and without arrhythmogenic right ventricular cardiomyopathy.
2026 · Vet Rec - Autoantibodies in Patients With Arrhythmogenic Cardiomyopathy Activate GSK-3β, Resulting in a Loss of Cardiomyocyte Cohesion.
2026 · Acta Physiol (Oxf) - Clinical value of anti-desmoglein-2 antibodies in arrhythmogenic right ventricular cardiomyopathy: real-world evidence.
2026 · Europace
Reference: B cellIEDB
1 publication
- Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.
2017 · Int J Infect Dis · RCR 0.7 · 19 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bundle of His cell-Purkinje myocyte adhesion involved in cell communication
- cell adhesion
- cell-cell adhesion
- desmosome organization
- homophilic cell adhesion via plasma membrane adhesion molecules
- maternal process involved in female pregnancy
- mesenchymal to epithelial transition
- negative regulation of apoptotic process
- negative regulation of endothelial cell differentiation
- negative regulation of epithelial to mesenchymal transition
- negative regulation of inflammatory response to wounding
- positive regulation of cell adhesion
- positive regulation of protein localization to cell-cell junction
- positive regulation of sprouting angiogenesis
- positive regulation of stem cell population maintenance
- Purkinje myocyte development
- regulation of heart rate by cardiac conduction
- regulation of ventricular cardiac muscle cell action potential
- response to progesterone
- stem cell proliferation
Molecular functions
- calcium ion binding
- cell adhesion molecule binding
- cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DSG2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DSG2 as an antibody target. Whether an autoantibody or antibody against DSG2 could matter depends on whether native DSG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DSG2 is annotated at the cell surface, where native DSG2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label DSG2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...